Sfoglia per Rivista HAEMATOLOGICA
T(10;11)(P13;P14-21) PICALM-MLLT10 ACUTE LEUKEMIA: CHARACTERIZATION OF TWO CASES WITH DIFFERENT PHENOTYPIC PRESENTATION
2021-01-01 Rinaldi, A; Cambò, B; Prezioso, L; Giaimo, Mt; Pagliaro, L; Dalla Palma, Ab; Sammarelli, G; Lastarza, R; Vallisa, D; Roti, G
[T-cell depletion today: pros and cons]
1989-01-01 Martelli, M. F; Aversa, Franco
Terminal deoxynucleotidyl transferase (TdT) levels in hairy cell leukemia.
1983-01-01 Bonati, Antonio; C., Ferrari; B., Starcich; F., Tedeschi
Terminal deoxynucleotidyl transferase: a nuclear marker of hemopoietic precursors. Biochemical, immunological and clinical aspects.
1986-01-01 Bonati, Antonio; B., Starcich
The activity of the PI-3 kinase inhibitor wortmannin on chronic myeloid leukemia cells in chronic phase
1996-01-01 Albertini, Roberto; C., Carlo Stella; Pinelli, Silvana; Lunghi, Paolo; E., Regazzi; D., Garau; V., Rizzoli; P. P., Dall'Aglio
The activity of the PI-3Kinase inhibitor wortmannin on chronic myeloid leukemia cells in chronic phase
1996-01-01 Albertini, Roberto; C., Carlo Stella; Pinelli, Silvana; Lunghi, Paolo; E., Regazzi; D., Garau; V., Rizzoli; P. P., Dall'Aglio; A., Bonati
The combination of MEK inhibitors and Arsenic Trioxide triggers in vitro and in vivo synergistic cytotoxicity in multiple myeloma through multiple signaling pathways
2008-01-01 Lunghi, P; Mazzera, L; Lombardi, G; Ricca, M; Corradi, Attilio; Cantoni, Anna Maria; Giuliani, Nicola; Salvatore, L; Riccioni, R; Costanzo, A; Testa, U; Levrero, M; Rizzoli, Vittorio; Bonati, Antonio
The proteasome inhibitor bortezomib stimulates the osteogenic differentiation of mesenchymal cells in vitro and may increase osteoblast formation in vivo in multiple myeloma patients.
2007-01-01 Giuliani, Nicola; Morandi, F; Tagliaferri, Sara; Lazzaretti, Mirca; Bonomini, S; Crugnola, M; Mancini, C; Martella, E; Ferrari, L; Tabilio, A; Rizzoli, Vittorio
The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment
2004-01-01 Giuliani, Nicola; Colla, S; Morandi, F; Rizzoli, Vittorio
Transcriptional and proteomic profiles of bone marrow CD14+ cells in multiple myeloma (MM) compared to smoldering MM and MGUS: overexpression of Interleukin (IL)-21 receptor and its involvement in MM-induced osteoclastogenesis
2014-01-01 Bolzoni, Marina; Ronchetti, D; Storti, Paola; Costa, Federica; Guasco, D; Agnelli, L; Marchica, Valentina; Dalla Palma, B; Accardi, F; Russo, F; Craviotto, Luisa; Bonomini, S; Thomas, B; Neri, A; Aversa, Franco; Giuliani, Nicola
The transcriptomic profile of CD138+ cells from patients with early progression from smoldering to active multiple myeloma remains substantially unchanged
2019-01-01 Storti, P.; Agnelli, L.; Palma, B. D.; Todoerti, K.; Marchica, V.; Accardi, F.; Sammarelli, G.; Deluca, F.; Toscani, D.; Costa, F.; Vicario, E.; Todaro, G.; Martell, E.; Neri, A.; Giuliani, N.
Tyrosine-phosphorylation of SHC adaptor proteins and activation of ERK-JNK/SAPK MAP kinases in acute myelogenous leukemia
1999-01-01 A., Bonati; Lunghi, Paolo; Albertini, Roberto; Pinelli, Silvana; Ridolo, Erminia; G., Valmadre; M., Sassi; I., Tassoni; A., Tabilio; C., Carlo Stella; Dall'Aglio, Pier Paolo; P. G., Pelicci
Updated results of a phase ii study using lenalidomide as post-transplant consolidation-maintenance therapy in elderly multiple myeloma patients
2011-01-01 F., Gay; S., Oliva; C., Crippa; V., Montefusco; F., Patriarca; Am, Liberati; S., Pezzatti; A., Levi; Giuliani, Nicola; P., Caraffa; T., Guglielmelli; N., Pescosta; E., Saraci; C., Cangialosi; A., Rauco; M., Rizzo; S., Ferrari; P., Corradini; M., Boccadoro; A., Palumbo
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project
2011-01-01 L., Pagano; M., Caira; A., Nosari; C., Cattaneo; R., Fanci; A., Bonini; N., Vianelli; Garzia, M. G.; M., Mancinelli; Tosti, M. E.; M., Tumbarello; P., Viale; Aversa, Franco; G., Rossi
VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group
2000-01-01 Santini, G; Coser, P; Congiu, Am; Salvagno, L; DE SOUZA, C; Sertoli, Mr; Olivieri, A; Chisesi, T; Rubagotti, A; Truini, M; Contu, A; Porcellini, A; Zambaldi, G; Nati, S; Marino, G; Rizzoli, Vittorio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| T(10;11)(P13;P14-21) PICALM-MLLT10 ACUTE LEUKEMIA: CHARACTERIZATION OF TWO CASES WITH DIFFERENT PHENOTYPIC PRESENTATION | 1-gen-2021 | Rinaldi, A; Cambò, B; Prezioso, L; Giaimo, Mt; Pagliaro, L; Dalla Palma, Ab; Sammarelli, G; Lastarza, R; Vallisa, D; Roti, G | |
| [T-cell depletion today: pros and cons] | 1-gen-1989 | Martelli, M. F; Aversa, Franco | |
| Terminal deoxynucleotidyl transferase (TdT) levels in hairy cell leukemia. | 1-gen-1983 | Bonati, Antonio; C., Ferrari; B., Starcich; F., Tedeschi | |
| Terminal deoxynucleotidyl transferase: a nuclear marker of hemopoietic precursors. Biochemical, immunological and clinical aspects. | 1-gen-1986 | Bonati, Antonio; B., Starcich | |
| The activity of the PI-3 kinase inhibitor wortmannin on chronic myeloid leukemia cells in chronic phase | 1-gen-1996 | Albertini, Roberto; C., Carlo Stella; Pinelli, Silvana; Lunghi, Paolo; E., Regazzi; D., Garau; V., Rizzoli; P. P., Dall'Aglio | |
| The activity of the PI-3Kinase inhibitor wortmannin on chronic myeloid leukemia cells in chronic phase | 1-gen-1996 | Albertini, Roberto; C., Carlo Stella; Pinelli, Silvana; Lunghi, Paolo; E., Regazzi; D., Garau; V., Rizzoli; P. P., Dall'Aglio; A., Bonati | |
| The combination of MEK inhibitors and Arsenic Trioxide triggers in vitro and in vivo synergistic cytotoxicity in multiple myeloma through multiple signaling pathways | 1-gen-2008 | Lunghi, P; Mazzera, L; Lombardi, G; Ricca, M; Corradi, Attilio; Cantoni, Anna Maria; Giuliani, Nicola; Salvatore, L; Riccioni, R; Costanzo, A; Testa, U; Levrero, M; Rizzoli, Vittorio; Bonati, Antonio | |
| The proteasome inhibitor bortezomib stimulates the osteogenic differentiation of mesenchymal cells in vitro and may increase osteoblast formation in vivo in multiple myeloma patients. | 1-gen-2007 | Giuliani, Nicola; Morandi, F; Tagliaferri, Sara; Lazzaretti, Mirca; Bonomini, S; Crugnola, M; Mancini, C; Martella, E; Ferrari, L; Tabilio, A; Rizzoli, Vittorio | |
| The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironment | 1-gen-2004 | Giuliani, Nicola; Colla, S; Morandi, F; Rizzoli, Vittorio | |
| Transcriptional and proteomic profiles of bone marrow CD14+ cells in multiple myeloma (MM) compared to smoldering MM and MGUS: overexpression of Interleukin (IL)-21 receptor and its involvement in MM-induced osteoclastogenesis | 1-gen-2014 | Bolzoni, Marina; Ronchetti, D; Storti, Paola; Costa, Federica; Guasco, D; Agnelli, L; Marchica, Valentina; Dalla Palma, B; Accardi, F; Russo, F; Craviotto, Luisa; Bonomini, S; Thomas, B; Neri, A; Aversa, Franco; Giuliani, Nicola | |
| The transcriptomic profile of CD138+ cells from patients with early progression from smoldering to active multiple myeloma remains substantially unchanged | 1-gen-2019 | Storti, P.; Agnelli, L.; Palma, B. D.; Todoerti, K.; Marchica, V.; Accardi, F.; Sammarelli, G.; Deluca, F.; Toscani, D.; Costa, F.; Vicario, E.; Todaro, G.; Martell, E.; Neri, A.; Giuliani, N. | |
| Tyrosine-phosphorylation of SHC adaptor proteins and activation of ERK-JNK/SAPK MAP kinases in acute myelogenous leukemia | 1-gen-1999 | A., Bonati; Lunghi, Paolo; Albertini, Roberto; Pinelli, Silvana; Ridolo, Erminia; G., Valmadre; M., Sassi; I., Tassoni; A., Tabilio; C., Carlo Stella; Dall'Aglio, Pier Paolo; P. G., Pelicci | |
| Updated results of a phase ii study using lenalidomide as post-transplant consolidation-maintenance therapy in elderly multiple myeloma patients | 1-gen-2011 | F., Gay; S., Oliva; C., Crippa; V., Montefusco; F., Patriarca; Am, Liberati; S., Pezzatti; A., Levi; Giuliani, Nicola; P., Caraffa; T., Guglielmelli; N., Pescosta; E., Saraci; C., Cangialosi; A., Rauco; M., Rizzo; S., Ferrari; P., Corradini; M., Boccadoro; A., Palumbo | |
| The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project | 1-gen-2011 | L., Pagano; M., Caira; A., Nosari; C., Cattaneo; R., Fanci; A., Bonini; N., Vianelli; Garzia, M. G.; M., Mancinelli; Tosti, M. E.; M., Tumbarello; P., Viale; Aversa, Franco; G., Rossi | |
| VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group | 1-gen-2000 | Santini, G; Coser, P; Congiu, Am; Salvagno, L; DE SOUZA, C; Sertoli, Mr; Olivieri, A; Chisesi, T; Rubagotti, A; Truini, M; Contu, A; Porcellini, A; Zambaldi, G; Nati, S; Marino, G; Rizzoli, Vittorio |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile